Lung cancer, Ovarian cancer, Small cell lung cancer
Results
Phase 1/2
This trial looked at nivolumab on its own or with another drug called ipilimumab. It was for people with cancer that had spread:
into surrounding tissues or
to another part of their body
This trial was open for people to join between 2013 and 2015. These results were published in 2016.
Recruitment start: 1 December 2013
Recruitment end: 7 October 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Jeff Evans
Bristol-Myers Squibb
NIHR Clinical Research Network: Cancer
Last reviewed: 08 Sept 2020
CRUK internal database number: 11750